CORT 42.27 (+6.45%)
US2183521028BiotechnologyBiotechnology

Corcept Therapeutics (CORT) Financial Metrics

This table shows a selected set of financial data points of Corcept Therapeutics (CORT). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 1.02 0 31.69 3.36B 0.18 482.38M 126.9M 109.64M 106.14M 135.55M
2022 0.95 0 21.39 2.17B 0.2 401.86M 119.91M 116.08M 101.42M 66.33M
2021 0.97 0 20.35 2.29B 0.23 365.98M 167.42M 127.95M 112.51M 77.62M
2020 0.92 0 28.48 3.02B 0.22 353.87M 150.73M 130.44M 106.01M 76.19M
2019 0.82 0 14.69 1.38B 0.26 306.49M 135.03M 111.61M 94.18M 315.31M
2018 0.6 0 22.45 1.69B 0.28 251.25M 115.37M 95.05M 75.41M 41.63M
2017 1.04 0 17.42 2.25B 0.89 159.2M 60.52M 52.96M 129.12M 31.06M
2016 0.07 0 103.57 843.17M 0.13 81.32M 18.2M 10.27M 8.14M 51.54M
2015 -0.06 0 -83 532.28M -0.15 50.29M 3.11M -3.29M -6.41M 40.44M
2014 -0.31 0 -9.65 302.93M -0.64 26.55M -27.55M -27.48M -31.38M 24.25M
2013 -0.46 0 -6.96 320.42M -0.57 10.36M -37.19M -41.42M -46.01M 54.88M
2012 -0.41 0 -3.5 133.01M -0.55 3.31M -36.17M -36.25M -38.05M 93.03M
2011 -0.39 0 -8.81 284.92M -1 0 -27.43M -32.35M -32.35M 39.64M
2010 -0.38 0 -10.16 263.78M -1.05 0 -22.29M -24.46M -25.97M 24.58M
2009 -0.38 0 -7.23 145.79M -0.91 29K -17.97M -20.06M -20.17M 23.87M
2008 -0.43 0 -2.38 47.66M -1.07 209K -18.37M -19.11M -20.06M 14.72M
2007 -0.34 0 -9.14 105.84M -0.84 482K -10.96M -11.56M -11.57M 11.43M
2006 -1.09 0 -1.13 28.09M -1.24 294K -24.55M -24.86M -24.87M 8.91M
2005 -0.89 0 -4.11 82.52M -0.52 0 -43.1M -19.39M -20.09M 3.82M
2004 -0.84 0 -7.42 115.25M -0.52 0 -117.62M -13.92M -15.53M 5.93M
2003 -1.13 0 0 0 -0.58 0 -10M -9.79M -9.81M 10.07M
2002 -2.75 0 0 0 -0.8 0 0 -18.5M -18.5M 18.4M
2001 -1.39 0 0 0 -0.59 0 0 -7.45M -7.45M 0
2000 0 0 0 0 0 0 0 0 0 1M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.